Disease
-

看微信网页:https://bit.ly/3gRDy8Q
View this page on WeChat: https://bit.ly/3gRDy8Q

 

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.

 

Sponsored by the Stanford China Program and the Stanford Center at Peking University.

The ravages of COVID-19 are now global. But the pandemic first struck in China, and the nation suffered a 6.8% decline in its first-quarter GDP. China is also the first country to move towards a recovery, however, rolling out government measures, re-opening businesses, and re-starting its economy. In this key moment, the Stanford China Program, in collaboration with alumni members of the Stanford Graduate School of Business, surveyed senior executives in China as their companies reboot their operations. In this two-part program, we first unveil potential trends and key takeaways from the survey. In the second half, we host a panel of prominent CxOs from China who give their insights and experiences rebooting their businesses. What are short-term challenges that companies in China currently face? What are some long-term implications of COVID-19 for their operational model, supply chain strategies, technology, and business digitization? What might they also mean, if any, for global trade relations and the future of globalization?

Agenda (in Pacific Time)

5:00-5:30 PM   Survey Presentation: Key Takeaways
5:30-6:15 PM   China CxO Panel: Discussion
6:15-6:45 PM   Audience Q&A

Agenda (in China)

8:00-8:30 AM   Survey Presentation: Key Takeaways
8:30-9:15 AM   China CxO Panel: Discussion
9:15-9:45 AM   Audience Q&A

 

PANEL SPEAKERS

Portrait of Shiqi WangAlvin Shiqi Wang (王世琪) has served as CEO and President of 21Vianet Group, Inc. since February 2018. Currently, Mr. Wang serves as Vice President of TUS Digital Group, a subsidiary of TUS Holdings, and serves on the board of directors of Beijing CIC Technology Co., Ltd. and Guangzhou Tuwei Technology Co., Ltd. . Mr. Wang has nearly 20 years of experience in the telecommunications industry, working at various renowned international companies, including 11 years with Ericsson, focusing primarily on strategy development and execution, corporate management, and equity investments. Mr. Wang received a bachelor's degree from Tsinghua University and an MBA from Peking University-Vlerick MBA Programme (BiMBA).

 

Portrait of Xiang WangXiang Wang (王翔) is President and Acting CFO of Xiaomi Corporation, responsible for platform functions and for assisting the CEO with Group operations. Mr. Wang joined Xiaomi Corporation in July 2015 served as its Senior Vice President and President for International Business, responsible for global expansion, IP strategy, and strategic partner relationship management. Mr. Wang has more than 20 years of experience in the semiconductor and communications fields, with great vision and comprehensive understanding of next-generation wireless communications. He has played an integral role in shaping Xiaomi’s international business operations including with respect to its intellectual property compliance, management and strategy throughout the world. In 2016, Mr. Wang put together an international team of sales and marketing teams to expand into more markets outside of China. Within just 3 years, he led his teams into over 90 markets. As of Q3 2019, Xiaomi’s international revenue accounted for 48.7% of its total revenue. Today, Xiaomi is ranked among top 5 smartphone brands in over 40 markets. Mr. Wang previously served as the Senior Vice President of Qualcomm and President of Qualcomm Greater China, leading the company’s business and operations in Greater China. Prior to that role, he was Vice President of Qualcomm CDMA Technology, responsible for Qualcomm chipset business and customer service in China. Under his leadership, Qualcomm rapidly extended and strengthened its partnerships with increasing numbers of Chinese manufacturing customers. Before joining Qualcomm, Mr. Wang held key positions in sales and marketing at internationally leading companies, including Motorola and Lucent/Agere. Mr. Wang earned his BSEE from Beijing Polytechnic University.

 

Image
Portrait of Simon Yang
Simon Yang (杨士宁) is the CEO of Yangtze Memory Technologies Co., Ltd. (YMTC), who brings YMTC to a new height in 3D NAND industry. As an experienced executive in the semiconductor industry for over 30 years, Dr. Yang served as the CEO of XMC, COO/CTO of SMIC, and CTO/SVP of Chartered Semiconductor (Now GlobalFoundries), in charge of fab operation and technical R&D. Before that, he was in the Portland Technology Development sector of Intel for more than 10 years, in which he led a series of technical R&D projects. Dr. Yang obtained a Bachelor’s Degree from Shanghai University of Science & Technology, and a Master’s Degree and a Doctoral Degree from Rensselaer Polytechnic Institute.

 

Portrait of Zhiqiang (ZZ) ZhangZhiqiang (ZZ) Zhang (张志强) is President of ABB in China since October 2018. He has extensive management experience and a deep understanding of the Chinese market, developed during his career at several large global companies over the past three decades. He joined ABB from Sandvik where he was Asia- Pacific Regional Holding Officer and President of Sandvik China, and Member of Sandvik Group Executive Committee. Prior to that, he held leadership positions at several other companies, including Nokia Siemens Networks, where he was President of the Greater China Region, and Siemens VDO Automotive, China, where he was President and CEO. Mr. Zhang is Non-Executive Board member of Georg Fischer AG (Switzerland) and Daetwyler Holding AG (Switzerland). He holds a bachelor’s degree in electronic engineering from Beijing Jiaotong University, China, and a master’s degree in business administration from the Smith School of Business at Queen’s University in Canada.

 

 

SURVEY PRESENTERS

Jean C. OiJean C. Oi is the William Haas Professor of Chinese Politics in the Department of Political Science and a senior fellow in the Freeman Spogli Institute for International Studies at Stanford University. She directs the China Program at the Walter H. Shorenstein Asia-Pacific Research Center and is the Lee Shau Kee Director of the Stanford Center at Peking University. Professor Oi has published extensively on China’s reforms. Recent books include Zouping Revisited: Adaptive Governance in a Chinese County, coedited with Steven Goldstein (Stanford University Press, 2018), and Challenges in the Process of China’s Urbanization, coedited with Karen Eggleston and Yiming Wang (2017). Current research is on fiscal reform and local government debt, continuing SOE reforms, and the Belt and Road Initiative.

 

Photo of Christopher ThomasChristopher Thomas was most recently a partner with McKinsey & Company. He served as co-Managing Partner for the Firm’s Global Digital Strategy service line as well as its Global IoT service line; and as the leader of its Asia Semiconductor Practice. Prior to McKinsey, Mr. Thomas spent ten years at Intel. He was the General Manager of Intel China, with joint ownership for the region’s $5 billion-plus P&L. In this role, he grew revenues by more than 50% and oversaw China’s successful elevation from a sales unit to an independent regional P&L business reporting directly into headquarters. Mr. Thomas began his career as a private equity investor at The Blackstone Group in New York City. He is currently a Visiting Professor at Tsinghua University, China’s leading educational institution. He received an MBA from Stanford Business School, where he was an Arjay Miller scholar; a Master of Arts in Political Science from Stanford University; and a Bachelor of Science in Economics, summa cum laude, from the Wharton School.

 

Image
Portrait of Xander Wu
Xander Wu (吴雪) oversees industry development and builds partnerships with the world’s top cloud computing companies for China Mobile International (USA). He helps clients expand their global footprint and advises companies on best practices for digital transformation. Mr. Wu has 13 years' experience in the global 4G and 5G industry, with a track record of achieving a number of the world’s first milestones in 5G and several de-facto standards for 4G and data networks. Mr. Wu graduated from Stanford Graduate School of Business, where he researched digital transformation and advised startups in the energy sector. He serves as a mentor at several incubators such as Plug and Play, helping startups find the right product/market fit and tailor go-to-market strategy.

 

Via Zoom Webinar.
Register at: https://bit.ly/2U2r30q

Alvin Shiqi Wang (王世琪) <br>CEO, President of 21Vianet Group, Inc.<br><br>
Xiang Wang (王翔) <br>President of Xiaomi Corporation<br><br>
Simon Yang (杨士宁) <br>CEO of Yangtze Memory Technologies Co., Ltd. (YMTC)<br><br>
Zhiqiang (ZZ) Zhang (张志强) <br>President, ABB (China)<br><br>
Jean C. Oi <br>Director of Shorenstein APARC China Program; William Haas Professor of Chinese Politics, Stanford University<br><br>
Christopher Thomas <br>Visiting Professor, Tsinghua University<br><br>
Xander Wu (吴雪) <br>China Mobile International (USA)<br><br>
Panel Discussions
News Type
News
Date
Paragraphs

Stanford University's Asian Liver Center (ALC) and the Global Business Group on Health jointly hosted the inaugural JoinJade for China Summit and Awards Ceremony at SCPKU on April 22, 2016.  29 major employers committed to a hepatitis B discrimination-free work environment were recognized at the event.  Lenovo, General Electric and IBM also participated in an employer panel to discuss key strategies for a discrimination-free work environment and next steps.

 

Image
employer panel

JoinJade for China is a joint initiative involving global organizations including the ALC in the U.S. and China, Global Business Group on Health, IBM, General Electric, Intel, Hewlett Packard Enterprise, and HP Inc.  The initiative focuses on building fully inclusive workplaces free from hepatitis B discrimination.  

Image
joinjade award

 

Image
joinjade award 2

 

The ALC at Stanford University is the first non-profit organization in the U.S. that addresses the disproportionately high rates of chronic hepatitis B infection and liver cancer in Asians and Asian Americans.  Founded in 1996, the center addresses the gap in the fight against hepatitis B through a four-pronged approach of collaboration, advocacy, research, and education and outreach (CARE).  The ultimate goal of the ALC is to eliminate the transmission and stigma of hepatitis B and reduce deaths from liver cancer and liver disease caused by chronic hepatitis B.

 

Photos courtesy of Stanford University's Asian Liver Center

Hero Image
All News button
1
News Type
News
Date
Paragraphs

Image
viewimage

 

Hua Tang, Stanford Associate Professor of Genetics, visited SCPKU as a faculty fellow in March 2015.  Below are the highlights of a conversation Professor Tang had with SCPKU in which she shares more details about her research and the contributions SCPKU made to her work in China.

 

Q: Describe your research and its connection to China

My research aims to develop statistical and computational methods for elucidating the genetic basis of human complex diseases. My current focus is on two related themes: identifying disease risk factors by integrating functional genomic information, and understanding factors that contribute to differential disease prevalence across human populations. My SCPKU faculty fellowship has given me the opportunity to explore new dimensions related to both themes.  Through connections I have made with scholars at Peking University (PKU), I will be able to combine biological knowledge and population-based association evidence in my efforts to identify genetic risk factors for complex diseases.  I also plan to compare epidemiologic data based on the East Asian population in the U.S. and epidemiological studies in China to understand the role of life-style risk factors, such as diet and physical activities, in ethnic health disparity.

 

Q: What got you interested in the study of human complex diseases?

I have always enjoyed mathematics, but it is very important to me that my work has direct benefit to people. Luckily, in college and during graduate school, I discovered that statistical and population genetics are areas in which I could use mathematical tools to gain insights relevant to human health. We are living in an era of big data; combining novel statistical models, efficient computational tools and large-scale biomedical data offers fantastic opportunities to make real contributions to medicine and public health.

 

Q: Why did you decide to apply for an SCPKU Faculty Fellowship?

I wanted to connect better with the scientific community in China.  I had already started communicating remotely with a PKU professor at PKU, whose research shares common goals with mine but who takes complementary approaches. The SCPKU faculty fellowship would allow me to travel to China and strengthen ties with faculty at PKU.  I also look forward to the opportunities of interacting with students at PKU.

 

Q: How valuable was SCPKU's team in supporting your fellowship at SCPKU?

Extremely valuable!   I got a nice office on the courtyard level, great IT and staff support. Also, I had the opportunity to interact with faculty from other departments for collaborations.

 

Q: What were your fellowship objectives and were they met?  Also, if applicable, aside from the fellowship, how did SCPKU help you to achieve your objectives?

My first visit to SCPKU in March was very productive and I was able further my research on the two themes I mentioned earlier.  I also taught a lecture in a concurrent SCPKU graduate seminar, through which I got to know the work of Professor Randall Stafford from the Stanford Prevention Research Center.  Professor Stafford was also an SCPKU faculty fellow and taught a graduate seminar at SCPKU this past spring focused on chronic disease in China.  I was able to participate in the seminar and establish new ties with instructors and participants of this  multidisciplinary seminar including Chinese scholars, health practitioners and government representatives from the Chinese Center for Disease Control and other health-related organizations. 

Being physically at SCPKU this past spring really helped to stimulate my research program. The fellowship has opened up many possibilities for interacting with scholars at Peking University and the broader scientific community in Beijing. I hope to expand these relationships by making several more trips to SCPKU. I am also very interested in organizing an SCPKU graduate seminar for the near future.
 

Q: Describe some highlights of your stay in China/SCPKU. 

Aside from meeting with my PKU contacts to further my research, I enjoyed participating in (both as an observer and teaching a lecture) Dr. Stafford’s graduate seminar on chronic diseases in China. I made many new connections in the Beijing science community and will host a visiting student in early 2016.  I also attended an SCPKU-hosted happy hour which included a Chinese rice wine tasting and musical performance on a Chinese zither or “guzheng.”

 

Q: List at least THREE words or thoughts that come to mind which best describe your experience at SCPKU. 

Adventure, exploration, collaboration.
 

Q: Any future plans in China? 

I plan to use the remaining funds from my SCPKU fellowship in the fall, and continue interaction with faculty at PKU and SCPKU.

 

Photo courtesy of Stanford University

Hero Image
All News button
1
News Type
News
Date
Paragraphs

Noncommunicable diseases (NCDs) have become the leading causes of death worldwide and China's increased NCD prevalence is of growing concern. Randall Stafford, Professor of Medicine in the Stanford Center for Research in Disease Prevention and SCPKU Faculty Fellow, led a symposium at the center last fall.  Entitled "Tackling China's Noncommunicable Diseases: Shared Origins, Costly Consequences, and the Need for Action," the symposium focused on China's NCD threats to public health and the urgent need for solutions.  The symposium summary was published earlier this month in the Chinese Medical Journal.

Hero Image
All News button
1
-

Speaker: Randall S. Stafford (moderator), Professor at Stanford Prevention Research Center

This symposium will highlight the public health threat posed by China’s non-­‐ communicable disease (NCD) epidemic, and focus on the role of research in developing an effective response. Prevalent NCDs (stroke, diabetes, heart disease, and cancer) share common origins linked to lifestyle changes and increasing disease risk factors spurred in part by successful economic development. These conditions and their complications, however, place a high burden on health care resources and reduce social capital growth. An effective response is possible, but will require a novel approach focusing on maintaining human function and wellness, strategies that impact multiple NCDs, new models of health care delivery, and greater integration of public health and clinical care.

Featured speakers include Prof. Linhong WANG (China Center for Disease Control), Prof. Lixin JIANG (National Centre for Cardiovascular Diseases), Prof. Yangfeng WU (Peking University Clinical Research Institute) Prof. Randall S. STAFFORD (Stanford Prevention Research Center), Prof. Sanjay BASU (Stanford Prevention Research Center).

 

Tackling China's Non-Communicable Diseases
Download pdf

Stanford Center at Peking University
The Lee Jung Sen Building
Peking University
No.5 Yiheyuan Road Haidian District
Beijing, P.R.China 100871

Directions/Map

Seminars
0
SCPKU Pre-Doctoral Fellow, Fall 2014
rhines_headshot_2.jpg
Allison Rhines received her PhD in Biology in 2015 with a research focus in mathematical modeling of infectious disease dynamics and control.  As an undergraduate at Stanford, her honors thesis on demographic change in China focused on rural-to-urban migration, and its impact on ideas and behaviors of preference for male children in the context of the One Child Policy; for this work, she conducted interviews with rural migrants in Mandarin in Xi'an, China.  Pursuing her master's as a Gates Scholar at the University of Cambridge, she used statistical models to relationship between demography and infectious disease.  Her PhD research at Stanford furthered her interests in the relationship between population sturcture and infectious disease dynamics.  At SCPKU, she collaborated with scholars at Peking University Health Sciences Center to study drug resistance in TB cases in Shenzhen.  Following completion of her PhD, she hopes to continue to pursue her focus in infectious disease control, with a particular interest in China.  
Subscribe to Disease